Transfusion ReactionTransfusion Related ComplicationAnesthesiaAnesthesia; ShockSide EffectFresh Blood StoolBlood Coagulation DisorderBlood Loss
Investigational drug(s) / intervention(s)
Transfusion
Transfusion: Transfusion of an hemostatic product
Study summary
the aim of this register is to collect exhaustively the different data available surrounding a transfusion act in the context of an active haemorrhage. The aim is to allow different modelling and analysis related to emergency transfusion.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* all patients who have received an hemostasis product
Exclusion Criteria:
* patient who refused to consent to data analysis and study participation
Primary outcome measure(s)
Hemostatic evolution through transfusion event — 12 hours evolution of APTT (seconds)
ROTEM measures evolution through transfusion event — 12 hours evolution of APTEMCT (seconds)
Haematologic measures evolution through transfusion event — 12 hours evolution of hemoglobin (g/dL)
ionic measures evolution through transfusion event — 12 hours evolution of lactate (mmol/L)
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
